Zai Lab Limited - ZLAB
About Gravity Analytica
Recent News
- 06.02.2025 - Zai Lab 2025 ASCO Investor Call
- 05.08.2025 - Zai Lab First Quarter 2025 Financial Results
- 05.08.2025 - Zai Lab First Quarter 2025 Financial Results
- 04.26.2025 - Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025
- 04.25.2025 - Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025
- 04.25.2025 - Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
- 04.23.2025 - Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
- 04.21.2025 - Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
- 04.21.2025 - Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors
- 04.21.2025 - Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors